Author Topic: IMMUNOPHENOTYPING  (Read 2439 times)

0 Members and 1 Guest are viewing this topic.

Offline Viza

  • Jr. Member
  • **
  • Posts: 48
  • Points: +15/-0
  • Gender: Male
  • Doctors fight to save lives
« on: March 17, 2009, 10:56:56 AM »
Since the development of the hybridoma technology, there have been major advances in the immunophenotypic characterization of heamopoietic malignancies.
Prior to the availability of monoclonal antibodies(McAbs), it was possible to distinguish B from T Lymphocytes.

So how many ways of testing Immunological cell markers?

we meet people trying to live theire lives and see what the Doctors is doing to help

Offline Diagnostic

  • Hero Member
  • *****
  • Posts: 281
  • Points: +112/-0
  • Gender: Male
  • Professional Diagnosis
« Reply #1 on: March 23, 2009, 09:15:10 PM »
T cell markers are (CD2, CD3, CD4, CD5, CD7, and CD8), B cell markers are (CD19 and CD20) and myeloid/monocytic markers are (CD13, CD14, CD15, and CD33)
In diagnosis think of the easy first.
Martin H. Fischer